Laurys Boudin

521 total citations
24 papers, 136 citations indexed

About

Laurys Boudin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Laurys Boudin has authored 24 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Laurys Boudin's work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Cells and Metastasis (3 papers). Laurys Boudin is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Cells and Metastasis (3 papers). Laurys Boudin collaborates with scholars based in France, Guadeloupe and United States. Laurys Boudin's co-authors include François Bertucci, Juliette Thariat, Pascal Finetti, Émilie Mamessier, Daniel Birnbaum, Anthony Gonçalvès, Patrice Viens, Pierre Yves Marcy, Peter A. van Dam and J.-B. Morvan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Laurys Boudin

22 papers receiving 133 citations

Peers

Laurys Boudin
A. Zeillemaker Netherlands
Risa Oda Japan
Busra Isik United States
Adrienne Prestridge United States
Wonae Lee South Korea
Laurys Boudin
Citations per year, relative to Laurys Boudin Laurys Boudin (= 1×) peers Д. Л. Ротин

Countries citing papers authored by Laurys Boudin

Since Specialization
Citations

This map shows the geographic impact of Laurys Boudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurys Boudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurys Boudin more than expected).

Fields of papers citing papers by Laurys Boudin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurys Boudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurys Boudin. The network helps show where Laurys Boudin may publish in the future.

Co-authorship network of co-authors of Laurys Boudin

This figure shows the co-authorship network connecting the top 25 collaborators of Laurys Boudin. A scholar is included among the top collaborators of Laurys Boudin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurys Boudin. Laurys Boudin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nonneville, Alexandre de, Pascal Finetti, Laurys Boudin, et al.. (2024). Abstract PO4-05-06: Hormone receptor-positive HER2-low metastatic breast cancer (mBC): evolution of HER2 status after CDK4/6 inhibitor treatment. Cancer Research. 84(9_Supplement). PO4–5. 1 indexed citations
2.
Nonneville, Alexandre de, Pascal Finetti, Laurys Boudin, et al.. (2024). Abstract PO3-02-07: HER2-low status in inflammatory breast cancer (IBC) is associated with hormone receptors positivity but not with pathological response to neoadjuvant chemotherapy or overall survival. Cancer Research. 84(9_Supplement). PO3–2. 1 indexed citations
4.
Marcy, Pierre Yves, Frédéric Bauduer, Juliette Thariat, et al.. (2023). Fast Track Management of Primary Thyroid Lymphoma in the Very Elderly Patient. Current Oncology. 30(6). 5816–5827. 1 indexed citations
5.
Nonneville, Alexandre de, Pascal Finetti, Laurys Boudin, et al.. (2023). Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype. Pharmaceutics. 15(3). 938–938. 4 indexed citations
6.
Lopresti, Alexia, Claire Acquaviva, Laurys Boudin, et al.. (2022). Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. Cancers. 14(4). 932–932. 6 indexed citations
7.
Thariat, Juliette, et al.. (2022). How to Manage a Patient with Ocular Metastases?. Biomedicines. 10(12). 3044–3044. 17 indexed citations
8.
Morvan, J.-B., et al.. (2022). Internal Jugular Vein Tumor Thrombus: A Tricky Question for the Thyroid Surgeon. Current Oncology. 29(12). 9235–9241. 4 indexed citations
9.
Boudin, Laurys, et al.. (2022). Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma. Current Oncology. 29(10). 7718–7731. 14 indexed citations
10.
Boudin, Laurys, Alexandre de Nonneville, Pascal Finetti, et al.. (2022). CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response. Journal of Translational Medicine. 20(1). 464–464. 5 indexed citations
11.
Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2021). How did we take care of our older cancer patients during the first COVID-19 wave? The French experience. Bulletin du Cancer. 108(6). 589–595. 1 indexed citations
12.
Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2020). Evaluation of medical practices in oncology in the context of the COVID‐19 pandemic in France: Physicians’ point of view: the PRATICOVID study. Cancer Medicine. 9(23). 8875–8883. 6 indexed citations
13.
Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2020). 1728P Evaluation of medical practices in oncology in a context of COVID-19 pandemic in France: Point of view of physicians, PRATICOVID study. Annals of Oncology. 31. S1013–S1013. 1 indexed citations
14.
Bourgouin, Stéphane, et al.. (2018). Disseminated Peritoneal Leiomyomatosis. Journal of Gastrointestinal Surgery. 23(3). 605–607. 3 indexed citations
15.
Boudin, Laurys, Anthony Gonçalvès, Renaud Sabatier, et al.. (2016). Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study. Journal of Cancer. 7(14). 2077–2084. 6 indexed citations
16.
Boudin, Laurys, Christian Chabannon, Renaud Sabatier, et al.. (2016). Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation. European Journal of Cancer. 57. 118–126. 4 indexed citations
17.
Boudin, Laurys, Nicolas Fakhry, Bruno Chetaille, et al.. (2014). Primary Synovial Sarcoma of the Thyroid Gland: Case Report and Review of the Literature. Case Reports in Oncology. 7(1). 6–13. 16 indexed citations
18.
Boudin, Laurys, et al.. (2014). Syndrome de Bing et Neel : à propos de 4 cas et revue de la littérature. La Revue de Médecine Interne. 36(6). 418–422. 2 indexed citations
20.
Gisserot, O., et al.. (2013). Peut-on prévenir ou guérir les cancers d’origine infectieuse ?. La Revue de Médecine Interne. 35(4). 259–263. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026